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Between February 1997 and December 2001, 311 adult-to-adult living donor liver transplants
(A-A LDLTs) were performed at the Asan Medical Center for patients above 20 years of age. Indications
for A-A LDLT were: chronic hepatitis B (203), chronic hepatitis C (5), hepatocellular carcinoma (64),
alcoholic cirrhosis (9), cryptogenic cirrhosis (4), secondary biliary cirrhosis (5), primary biliary
cirrhosis (1), Wilson’s disease (2), autoimmune hepatitis (1), hepatic tuberculosis (1),
cholangiocarcinoma (1), fulminant hepatic failure (14) and primary non-function of cadaveric liver
graft (1). Of 311 A-A LDLTs, 36 were of medical high urgency, 20 were for acute and subacute hepatic
failure, 15 were for hepato-renal syndrome and 1 was for primary non-function. Recipient age ranged
from 27 to 64 years. Donor age ranged from 16 to 62 years. There was no donor mortality. Implanted
liver grafts were categorized into seven types: 175 modified right lobe (MRL), 70 left lobe, 32 right
lobe, 20 dual grafts, 10 left lobe plus caudate lobe, three extended right lobe and one posterior
segment. In MRL, the tributaries of the middle hepatic vein were reconstructed by interpositioning a
vein graft. Indication for dual graft implantation was the same as single graft A-A LDLT, and four of
20 were emergency cases. Of 20 dual grafts, 14 received two left lobes, four received a left lobe and
a lateral segment, one received a right lobe and a left lobe and one received a lateral segment and a
posterior segment. Graft volume ranged from 28% to 83% of the standard liver volume of the
recipients. There were 33 (10.6%) in-hospital mortalities (< 4 months) among the 310 patients after
311 A-A LDLTs. Of the 36 patients receiving emergency transplants, 31 survived. These encouraging
results justify the expansion of A-A LDLT in coping with increasing demands, even in urgent situations.
We have aimed to introduce the establishment of the efficacy of A-A LDLT in various end-stage chronic
and acute liver diseases, as well as new technical advances to overcome small graft-size syndrome by
using dual-graft implantation and MRL, both of which were first developed in our department. (Asian
J Surg 2002;25(4):277–84)
INTRODUCTION
After the introduction of living donor liver transplan-
tation (LDLT) as a life-saving treatment modality for
children with end-stage liver disease,1 attempts have
been made to extend this innovative procedure to adult
patients,2 especially in East Asia where brain-dead donor
organ procurement is severely restricted. Although LDLT
has several advantages over cadaveric donor liver
transplantation (CDLT), such as a good graft quality, better
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histocompatibility, a shorter cold ischaemia time and
a timely operation within a shorter waiting period, the
main limitation for successful adult-to-adult (A-A) LDLT is
graft-size insufficiency,3 in which the graft cannot meet
the metabolic demands of the recipient. Furthermore, it
is still not clear whether A-A LDLT is safely applicable in
the same situations as CDLT, particularly for urgent or
emergency cases. Our purpose is to establish the efficacy of
A-A LDLT in various end-stage liver diseases and to intro-
duce the new technical advances developed at our centre
to overcome the problem of small-for-size graft syndrome.
MATERIALS AND METHODS
From the first clinical cadaveric liver transplantation
on August 1992 at the Asan Medical Center, Ulsan
University Medical School until December 2001, 493
liver transplants (109 CDLTs and 384 LDLTs) were
performed. Since February 1997, 311 adult-to-adult
(> 20 years) LDLTs have been performed, while 73
paediatric LDLTs have been performed since December
1994 (Figure 1).
Indications for A-A LDLTs are listed in Figure 2. Of
311 A-A LDLTs, 36 were in United Network of Organ
Sharing (UNOS) status I and IIa (20 fulminant hepatic
failures, 15 hepato-renal syndrome, one primary
non-function of the graft) and required urgent surgery.
ABO-blood groups were identical or compatible in all
cases. Recipient age ranged from 27 to 64 years; donor
age ranged from 16 to 62 years. All donations were
approved by the ethics committee of our local authority
Figure 1. Annual number of living donor liver transplants (LDLTs) at the Asan Medical Center, Ulsan University Medical
School. (Dark-coloured bar = paediatric LDLT, light-coloured bar = adult LDLT)
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Figure 2. Indications for adult-to-adult living donor liver
transplantation. HBV-LC = hepatitis B virus-liver cirrhosis;
HCC = hepatocellular carcinoma; FHF = fulminant hepatic
failure; HCV = hepatitis C virus; SBC = secondary biliary
cirrhosis; PBC = primary biliary cirrhosis; AIH = autoimmune
hepatitis; CCC = cholangiocellular carcinoma; PNF = primary
non-function; H-R syndr = hepato-renal syndrome.
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Figure 3. Types of liver grafts in 311 adult-to-adult living donor liver
transplants. MRL = modified right lobe; LL = left lobe; RL = right lobe; LL+S1 =
left lobe plus segment 1; LLS = left lateral segment; ERL = extended right lobe;
PS = posterior segment.
Figure 4. Scheme for modified right lobe (MRL) liver grafting. RHV =
right hepatic vein; MHV = middle hepatic vein; LHV = left hepatic vein; V5 =
hepatic venous tributary from segment 5; V8 = hepatic venous tributary from
segment 8.
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including MHV, which may
increase operative risk to
living donor
Modified right lobe graft
was commonly found; thus, we now routinely perform
preoperative liver biopsy of every donor. Recently,
invasive conventional angiography has been replaced
by 3-dimensional CT angiography. At the beginning of
our A-A LDLT programme, the minimum required graft
volume was greater than 30% of the standard liver
volume (SLV) of the recipient, and later changed to
greater than 40% of SLV of the recipient. The percentage
of the graft volume was calculated using the following
formula developed in our department:
BSA (m2) = BW (kg)0.425 x height (cm)0.725 x 0.007184
SLV (ml) = 691 x BSA (m2) + 95
Percentage of graft volume (%) = graft
volume(g)/SLV of recipient(ml) x 100, where
BSA (m2) is body surface area, BW (kg) is
body weight.
The initial criterion for using a right
lobe graft was that the estimated volume
of a left lobe graft of the potential donor
would be less than 40% of SLV of the
recipient. Implanted liver grafts were
categorized into seven types from 320
donors in 311 A-A LDLTs: modified right
lobe (176), left lobe (83), right lobe (32),
left lobe plus caudate lobe (10), left lateral
segment (four [all were used for dual graft
implantation]), extended right lobe (three)
and posterior segment (two[one was used
for dual graft implantation]) (Figure 3). In
modified right lobe graft, the tributaries
of the middle hepatic vein from the
anterior segment of the right liver graft
(V5, V8) was reconstructed by way of vein
graft interposition (autogenous or
cadaveric homologous) to prevent
possible congestion of the anterior
segment (Figure 4).4
Noticeably, dual-graft implantation
into a single recipient was performed in
20 patients from March 2000 to December
2001. The indication for this procedure
was the same as that of single graft A-A
LDLT, and four of 20 were emergencies
(two fulminant hepatic failure, two
hepato-renal syndrome). Of 20 recipients,
14 received two left lobes, four received
and the Korean Network of Organ Sharing (KONOS),
which is affiliated with the Korean Ministry of Health.
The legal age of consent for donation in Korea is 16 years
if the recipient is their parent, but in other circumstances,
the legal age for consent is 20 years.
Pre-transplantation evaluation of donors include liver
function chemistry, viral markers for both hepatitis B and
C, survey for cytomegalovirus, ultrasound, volumetric
computed tomography (CT) of the liver and hepatic
angiography. Endoscopic retrograde cholangiopan-
creatography is not done preoperatively. Liver biopsy
was performed only when steatosis was suspected on
a clinical or imaging basis. However, our experience
was that severe steatosis (>75%) on normal imaging
320 Living Donors
MRL 176
LL 83
RL 32
LL + S1 10
LLS 4
ERL 3
PS 2
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Figrue 5. Adult-to-adult living donor liver transplantation using dual grafts.
a left lobe and a lateral segment (one a cadaveric donor’s
lateral segment) and one received a lateral segment and
a posterior segment (Figure 5). In order to minimize cold
ischaemia time of the graft, donor and recipient operations
were started simult-aneously and the hepatic artery,
portal and hepatic veins of the graft were not divided until
the recipient was ready to receive the graft. The procured
graft was flushed with 1 L of cold (4°C) HTK solution
through the portal vein at the back table. At the back
table, reconstruction of the tributaries of the middle
hepatic veins of the right lobe graft (V5, V8) were performed
by connecting V5 and/or V8 with the interposition vein
graft obtained from the recipient’s saphenous vein,
umbilical collateral vein, or cryopreserved cadaveric
iliac vein, when V5 and/or V8 had a calibre larger than
5 mm. In the recipient, passive veno-venous bypass
(Anthron tube, Toray Industries, Tokyo) was used to
divert portal inflow into the femoral vein during the
anhepatic phase, thus, avoiding splanchnic venous
congestion in the absence of large coronary vein collaterals
or spontaneous spleno-renal shunt. All sizeable accessory
right hepatic veins (> 5 mm) were reconstructed to
provide sufficient venous outflow. Microscope-assisted
hepatic arterial anastomosis was performed in all cases.
Biliary reconstruction has been performed preferentially
by duct- to-duct  anastomosis  rather than by
hepaticojejunostomy since early 2000.
Immunosuppression was induced with methyl
prednisolone, tacrolimus or cyclosporine. If renal function
was not optimal, mycophenolate mofetil was used as
the primary immunosuppressive agent until renal
function returned to normal. To stabilize graft function,
gabexate mesilate (Foy, Ono Pharmaceutical
Co., Japan) and alprostadil (Eglandin, WelFide
Co., Korea) were administered after graft
reperfusion. Anticoagulation therapy includ-
ing administration of low-molecular weight
heparin, anti-thrombin III and maintenance
of haematocrit within the range of 25%
to 30% was maintained for 2 weeks after
surgery to prevent hepatic artery thrombosis,
especially when the calibre of the hepatic
artery was smaller than 2 mm.
RESULTS
Of 320 living donors (262 were more than
right lobe donors) for 311 A-A LDLTs, there
was no mortality. The minimal remaining
Figure 6. Scheme for radiopaque rubber-band tagging (RBT) to accurately
localize the division site of the hepatic duct during donor hepatectomy. A)
Black arrow indicates the rubber-band tag and holding suture at the right
hepatic duct orifice. B) Intraoperative cholangiography clearly shows the
relation between the rubber band and the proposed division site of the bile
duct. White arrow indicates the rubber-band tagged at the right hepatic duct.
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Table 1. In-hospital mortality (< 4 months posttransplant) among 310 patients after 311 adult-to-adult living donor liver
transplantations.
Causative factors Left lobe Right lobe Dual PS
grafts (n = 80) grafts (n = 210) grafts (n = 20) graft (n = 1)
HAT 2 2
HA anastomotic leak 1
PVT 1
RHV outflow obstruction 2
AS congestion 1
Biliary leakage 1 ( IFN-f )
Intra-abdominal haemorrhage 1
Postreperfusion syndrome 1
Iatrogenic subclavian artery injury 1
Myocardial infarction 1
Congestive heart failure 1
Intracranial haemorrhage 1
Seizure 1
Intestinal gangrene 1
LGI haemorrhage 1
Necrotizing pancreatitis 1
Sepsis 1 2
HCC recurrence 1
Acute rejection 1 1
Massive haemorrhagic necrosis, graft 3
Cholestatic dysfunction, graft 2 1 1
Total 13 (16%)  17 (8%) 3 (15%) 0 (0%) 33 (10.6%)
PS = posterior segment; HAT = hepatic artery thrombosis; HA = hepatic artery; PVT = portal vein thrombosis; RHV = right
hepatic vein, AS = anterior segment; LGI = lower gastrointestinal; HCC = hepatocellular carcinoma.
liver volume of a donor after right lobectomy was calculated
to be 27% of the total liver volume of the donor, in whom
postoperative serum bilirubin was elevated to 9.0 mg/dL.
Major donor complications included two donors with
postoperative bleeding requiring re-exploration, three
with that biliary strictures that needed balloon dilatation
and internal stenting, one with portal vein stenosis requiring
percutaneous metallic stenting, one with portal vein
thrombosis treated by thrombectomy and intraoperative
metallic stent insertion via the interior mesenteric vein,
and another developed renal failure due to contrast allergy
following hepatic angiography. All of these major compli-
cations developed after right lobe harvest.
If the remaining liver volume of the donor after right
lobectomy was less than 30% of the total liver volume,
intraportal glucose and insulin infusion were given to
accelerate the regeneration of donor’s liver until the 7th
postoperative day. The mean blood loss during donor
hepatectomy was 590 ± 480 ml for right lobectomy and
475 ± 42 ml for left lobectomy. Five donors required
non-autologous blood transfusion. The mean hospital
stay was 12 days (range, 10 to 28 days).
In recipients, the ratio of graft volume to SLV of the
recipient ranged from 28% to 83%. All right lobe grafts
met the minimal required graft volume of > 40% of the
SLV of the recipients.
The most common complication in recipients was
biliary leakage and stricture. In 1998, biliary complications
were as high as 25%, but after the introduction of rubber
band tagging (RBT) to obtain a single bile duct opening
(Figure 6), it has decreased to less than 5%. The RBT
method was first developed in our department. To
determine the bile duct division site, a short segment of
radiopaque rubber band (10–15 mm in length, 1 mm in
diameter), which is a fragment of the blue-coloured
radiopaque marker attached to a commercial surgical
gauze, was tagged transversely on the proposed division
site of the hepatic duct by holding sutures to prevent the
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displacement of the radiopaque marker during
manipulation of the liver. Subsequently, intraoperative
cholangiography (IOC) via the cystic duct was checked
to identify the relation between the RBT and the proposed
division site of the hepatic duct. If the RBT was properly
positioned at the planned division site, careful division of
the duct was performed. If the RBT was not properly
positioned, another RBT was applied to the planned
division site and IOC was checked repeatedly to confirm
correct positioning.
There were 33 in-hospital mortalities (< 4 months
posttransplant) among recipients; 13 of 80 left lobe grafts
(16%), 17 of 210 right lobe grafts (8%) and three of 20
dual lobes grafts (15%) (Table 1).
Technical complications leading to patients’ deaths
were: three hepatic artery thromboses, one hepatic artery
anastomotic leak caused by size discrepancy of recipient’s
splenic artery and donor’s left hepatic artery (more than
three-fold larger) in which the patient’s hepatic artery was
occluded by repeated transarterial chemoembolization
for hepatocellular carcinoma and the recipient’s large
splenic artery was mobilized to provide an arterial inflow.
There was also one portal vein thrombosis caused by
kinking of cadaveric iliac vein jump graft, two cases of
right hepatic vein outflow obstruction due to displacement
of the vein anastomosis site caused by too large right liver
graft being placed too far to the right and abdominal
closure by force, one case of anterior segment congestion
and infarct of the right lobe graft caused by impaired
middle hepatic venous outflow drainage,5 one persistent
Table 2. Results of liver transplantation at the Asan Medical Center
Year 1992–1993 1994–1996 1997–1998 1999 2000 2001
CDLT
   Graft survival 3/7 (43%) 14/20 (70%) 19/26 (73%) 28/30 (93%) 15/15 (100%) 8/11 (73%)
   Patient discharge 3/6 (50%) 14/20 (70%) 19/26 (73%)   28/28 (100%) 15/15 (100%) 9/11 (82%)
LDLT
   Paediatric
      Graft survival 14/16 (88%) 20/22 (91%) 12/14 (86%) 12/14 (86%) 7/7 (100%)
      Patient discharge 14/16 (88%) 20/22 (91%) 12/14 (86%) 12/14 (86%) 7/7 (100%)
   Adult
      Graft survival 24/36 (67%) 61/68 (90%) 84/91 (92%) 106/116 (91%)
      Patient discharge 24/35 (69%) 63/68 (93%) 84/91 (92%) 106/116 (91%)
In August 1992, the first cadaveric donor liver transplantation was performed. In December 1994, our first paediatric living donor
liver transplantation was performed. In February 1997, our first adult-to-adult living donor liver transplantation was performed.
CDLT = cadaveric donor liver transplantation; LDLT = living donor liver transplantation.
bile duct anastomotic leak complicated by sepsis with
associated interferon-induced pancytopenia for hepatitis
C recurrence and one case of repeated intra-abdominal
haemorrhage from an unidentified site.
Acute rejection developed in fewer than 30% of
recipients, most of them responding to pulsed steroid
therapy. There was one intraoperative death due to
postreperfusion syndrome — the patient underwent
emergency surgery for hepatitis B virus (HBV)-induced
acute hepatic failure with anuria and pulmonary oedema.
Interestingly, we has three cases of massive haemorrhagic
necrosis of right lobe grafts, showing rapid elevation of
transaminase, deteriorating graft function and normal
angiography and Doppler flow between the 5th and 7th
day posttransplant. Patient survival 6 months
posttransplant was 69% between 1997 and 1998, 93% in
1999, 92% in 2000 and 91% in 2001 (Table 2).
DISCUSSION
In Korea, liver transplantation is now becoming a
widely accepted treatment modality for both acute and
chronic liver failure, with the number of liver transplants
increasing year by year. There were 212 liver trans-
plantations performed at 23 centres in 2000 (Table 3).
Because cadaveric donor resources are severely
restricted in our country, LDLT was first introduced as a
possible solution for the persistent shortage of cadaveric
organs for paediatric patients in 1994 by our department.
Since Hashikura et al reported the first successful A-A
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LDLT,2 the use of this innovative treatment procedure has
steadily increased in Japan, Hong Kong, Taiwan and also
in Korea. Nonetheless, extension of LDLT to adult patients
has been met with limited success largely due to the small-
size graft syndrome, if only the left lobe is used for grafting.
Lo et al published the first report on their cumulative
experience with right lobe A-A LDLT.6 The first successful
A-A LDLT using a right lobe in our country was performed
at our department in July 1997 for a 43-year-old HBV-
cirrhotic, the donor being his wife.
With our first experience of five right lobe grafts (not
including a middle hepatic vein), two grafts developed
severe congestion of the anterior segment (AS),
complicated by prolonged massive ascites and severe
graft dysfunction, leading to death in one recipient.5
Nakamura and Tsuzuki reported that the right hepatic
vein drains the posterior segment and the middle hepatic
vein predominantly drains the AS.7 In these incidences,
preparation of a right liver graft without middle hepatic
venous outflow drainage resulted in the isolation of
venous tributaries from the anterior segment, which
evoked congestion and finally infarction of the AS. This
led us to develop the modified right lobe graft to avoid AS
congestion in late 1998.4 Besides the extended right lobe
graft, preservation of middle hepatic vein drainage of a
right lobe graft is possible by the modified right lobe graft
in which the hepatic venous tributaries of the AS (> 5 mm
calibre) are reconstructed via autogenous interposition
vein graft (recipient’s great saphenous vein, external iliac
vein, umbilical collateral vein or cryopreserved cadaveric
cavo-iliac vein) into the recipient’s middle and/or left
hepatic veins or inferior vena cava.
Once congestion injury of the AS develops, future
graft function depends on the volume of the posterior
segment. If the estimated liver volume of the posterior
segment of the right lobe graft is under 35% of SLV of the
recipient, reconstruction of the middle hepatic vein
tributaries is inidicated.
Sugawara and Makuuchi suggested a donor graft
volume of 30% of the SLV as an adequate liver volume for
recipients with metabolic liver disease and 40% in
cholestatic liver disease.3 Lo et al reported survival with
grafts that were only 25% of the SLV of the recipients who
had fulminant hepatic failure.8 In our study, two deaths
were related to graft failure, caused by small-for-size graft
syndrome (30% and 31% each, both suffering from
chronic parenchymal liver disease). Following this, we
increased the acceptable minimal graft volume to greater
than 40% of the SLV of the recipient.
Insufficient graft size has been an obstacle to the
expansion of A-A LDLT, especially if the donor graft is
taken only from the left lobe. To expand the application
of A-A LDLT, right lobe grafts have been widely used, but
the risk to the donor is high. The safety of donor right
lobectomy varies, mainly depending on the remaining
volume of the left lobe. Although a donor may have a large
right lobe that is suitable as a graft for a larger-size
recipient, the remaining left lobe may be too small to be
compatible with donor safety in many cases. If this is the
case, the potential donor cannot be accepted. As an
alternative, we developed dual-graft transplantation from
two donors into one recipient to solve not only the graft
size insufficiency but also to minimize donor risk.9 Our
patient survival rate after A-A LDLT is comparable to the
results of cadaveric full-size liver transplantation, even in
urgent cases.
A-A LDLT provides a new donor pool in East Asia,
where cadaveric organ donation is severely restricted.
Furthermore, A-A LDLT using a right lobe graft has further
extended the limitation created by the size of the recipient.
Nonetheless, the donor risk involved in right lobe
harvesting is still high, particularly when the remaining
liver volume of the donor is less than 35% of his or her
total liver volume. Careful assessment of potential donor
complications should be continued perioperatively in
view of donor safety.
Table 3. Status of liver transplantation (both cadaveric
and living donor) in Korea
Year Number of Number of
transplantation hospitals transplants
1988 1 1
1992 3 7
1993 4 8
1994 6 28
1995 9 25
1996 13 45
1997 15 70
1998 20 96
1999 23 195
2000 23 212
Total 23 697
The first liver transplantation was performed in 1988, using
a cadaveric full-size liver graft. In 2000, 212 liver transplants
were performed at 23 centres. However, only five centres
perform more than 10 liver transplants per year.
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